Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Reexamination Certificate
2005-01-28
2008-11-18
Haghighatian, Mina (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
C424S043000, C424S434000
Reexamination Certificate
active
07452524
ABSTRACT:
A method for improvement of tolerance for therapeutically effective agents delivered by inhalation comprising a pretreatment of a patient with a nebulized lidocaine or a lidocaine-like compound administered immediately or up to about thirty minutes before administration of the primary therapeutically effective agent. The pretreatment of the patient with the nebulized lidocaine or a lidocaine-like compound improves airway tolerance and deposition of the agent in the lungs and makes such deposition more safe, efficacious, controllable and predictable. The method of the invention is especially useful for enhancement of deposition of immunosuppressive agents in the lung(s) of transplant patients, improved tolerance of the drugs by reducing cough, and improving pulmonary drug deposition.
REFERENCES:
patent: 5837713 (1998-11-01), Gleich
patent: 6362197 (2002-03-01), Page et al.
patent: 6576224 (2003-06-01), Osbakken et al.
patent: 6962151 (2005-11-01), Knoch et al.
patent: 2002/0006901 (2002-01-01), Iacono
Pari, eFlow News Release, May 18, 2004.
Scott Trochtenberg, Nebulized Lidocaine in the Treatment of Refractory Cough,Chest, 105:1592-1593, (May 1994).
Robert V. Sanders, et al. Prolonged Suppression of Cough After Inhalation of Lidocaine in a Patient With Sarcoid,JAMA, 252/17: 2456-2457, (Nov. 2, 1984).
Paul M. Suratt, et al., Deaths and Complications Associated With Fiberoptic Bronchoscopy,Chest, 69/6:747-751, (Jun. 1976).
John J. Howard, et al., Adult Respiratory Distress Syndrome Following Administration of Lidocaine,Chest, 81/5:644-645, (May 1982).
Robert A. Promisloff, et al., Death From ARDS and Cardiovascular Collapse Following Lidocaine Administration,Chest, 83/3:585, (Mar. 1983).
Bradford J. Woelke, et al., ARDS After Local Lidocaine Administration,Chest, 83/6:933-934, (Jun. 1983).
Paul L. Enright, et al., Effect of Lidocaine on the Ventilatory and Airway Responses to Exercise in Asthmatics,American Review of Respiratory Disease, 122:823-828, (1980).
H. Groeben, et al., Lidocaine Inhalation for Local Anaesthesia and Attenuation of Bronchial Hyper-reactivity With Least Airway Irritation. Effect of Three Different Dose Regimens,European Journal of Anaesthesiology, 17:672-679, (2000).
Michael R. Cohen, et al., Topical Anesthesia and Swallowing,JAMA, 236/6:562, (Aug. 9, 1976).
Loren W. Hunt, et al., Effect of Nebulized Lidocaine on Severe Glucocorticoid-Dependent Asthma,Mayo Clin Proc, 71:361-368, (1996).
M. L. Decco, et al., Nebulized Lidocaine in the Treatment of Severe Asthma in Children: A Pilot Study,Annals of Allergy, Asthma&Immunology, 82:29-31, (Jan. 1999).
The International Journal of Tuberculosis and Lung Disease, S32, Poster Sessions, (Oct. 1-4, 1997).
Harold Groeben, et al., Intravenous Lidocaine and Oral Mexiletine Block Reflex Bronchoconstriction in Asthmatic Subjects,Am J. Respir Crit Care Med, 154:885-888, (1996).
Earl B. Weiss, et al., The Response to Lidocaine in Bronchial Asthma,Chest, 72/4:429-438, (Oct. 1977).
Lisa A. Whims, et al., Nebulized Lidocaine in the Treatment of Refractory Tussive Syncope,JAOA, 98/3:170-172, (Mar. 1998).
Scott Trochtenberg, Nebulized Lidocaine in the Treatment of Refractory Cough,Chest, 105/5:1592-1593, (May 1994).
Robert V. Sanders, et al., Prolonged Suppression of Cough After Inhalation of Lidocaine in a Patient With Sarcoid,JAMA, 252/17:2456-2457, (Nov. 2, 1984).
Peter Dure-Smith, et al. Bronchography: The Rational Use of Premedication and Local Anesthesia,Journal of the Canadian Association of Radiologists, 22:199-200, (Sep. 1971).
Emmanuel Udezue, Lidocaine Inhalation for Cough Suppression, Clinical Notes, pp. 206-207, 2000.
F. A. Naveira, et al., Treatment of Persistent Cough After Stellate Ganglion Block,Regional Anesthesia, 18/5:312-314, (1993).
J. J. Adcock, et al., RSD931, A Novel Anti-tussive Agent Acting on Airway Sensory Nerves,British Journal of Pharmacology, 138:407-416, (2003).
M. Jeffery Mador, Effect of Nebulized Lidocaine on Ventilatory Response to CO2in Healthy Subjects,The American Physiological Society, pp. 1419-1424, (1993).
Thomas G. O'Riordan, et al., Delivery and Distribution of Aerosolized Cyclosporine in Lung Allograft Recipients,Am J Respir Crit Care Med, 151:516-521, (1995).
Aldo T. Iacono, et al., Aerosolized Cyclosporine in Lung Recipients With Refractory Chronic Rejection,Am J Respir Crit Care Med, 153:1451-1455, (1996).
Aldo T. Iacono, et al., Dose-Related Reversal of Acute Lung Rejection by Aerosolized Cyclosporine,Am J Respir Crit Care Med, 155:1690-1698, (1997).
J. S. LaKind, et al., A Review of the Comparative Mammalian Toxicity of Ethylene Glycol and Propylene Glycol,Critical Reviews in Technology, 29/4:331-361, (1999).
G. Wieslander, et al., Experimental Exposure to Propylene Glycol Mist in Aviation Emergency Training: Acute Ocular and Respiratory Effects,Occup. Environ Med, 58:649-655, (2001).
Baker William R.
Hofmann Thomas
Montgomery Alan Bruce
Stapleton Kevin
Gilead Sciences, Inc.
Haghighatian Mina
Peters Verny LLP
Verny Hana
LandOfFree
Method for improvement of tolerance for therapeutically... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for improvement of tolerance for therapeutically..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for improvement of tolerance for therapeutically... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4033624